114
Participants
Start Date
February 29, 2004
Study Completion Date
July 31, 2005
G-CSF Granulocyte-Colony Stimulating Factor
Patients were randomly assigned to receive subcutaneously a daily dose of 10 microg/kg of G-CSF for 5 days.
Placebo
Patients were randomly assigned to receive subcutaneously either a daily dose of 10 microg/kg of G-CSF or placebo for 5 days.
Deutsches Herzzentrum, Munich
671. Medizinische Klinik, Klinikum rechts der Isar, Munich
Wilhelm Sander Foundation
UNKNOWN
Schulz Foundation
UNKNOWN
Else Kröner Fresenius Foundation
OTHER
Deutsches Herzzentrum Muenchen
OTHER